DATA PLANS
Download historical data for 20 million indicators using your browser.
Subscription Plans
|
Features
API GATEWAY
Direct access to our data from your apps using any programing language.
Features
|
Documentation
Already a user?
Login
Light Mode
Dark Mode
Calendar
News
Markets
Currencies
Stocks
Commodities
Bonds
Crypto
Earnings
Holidays
Indicators
Inflation Rate
Interest Rate
Unemployment Rate
GDP Growth
GDP per Capita
GDP Value
Current Account
Credit Rating
Wages Growth
Gold Reserves
Government Debt
Crude Oil Production
Gasoline Prices
Heatmap Table
More Indicators
Countries
United States
China
Japan
Canada
Australia
Brazil
Russia
India
Euro Area
United Kingdom
Germany
France
Italy
Spain
Switzerland
Singapore
More Countries
Forecasts
Countries
Indicators
Currencies
Stocks
Commodities
Bonds
Crypto
Charles River Laboratories | CRL - Cash And Equivalent
Chart
Quotes
Financials
1Y
5Y
10Y
25Y
MAX
Chart
Column
Line
Area
Spline
Splinearea
Trend
Average(4)
Histogram
Variance
Mean
Maximum
Minimum
Compare
Export
API
Embed
Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.
Features
Questions?
Contact us
Already a Member?
Login
The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.
API Features
Documentation
Interested?
Click here to contact us
Please Paste this Code in your Website
width
height
Preview
Charles River Laboratories
Charles River Laboratories reported $201.59M in Cash and Equivalent for its fiscal quarter ending in March of 2023.
Cash And Equivalent
Change
Date
Agilent
A:US
USD 1.18B
75M
Mar/2023
Align Technology
ALGN:US
USD 832.38M
109.67M
Mar/2023
AmerisourceBergen
ABC:US
USD 1.54B
152.8M
Mar/2023
Bio-Rad Laboratories
BIO:US
USD 464.14M
29.92M
Mar/2023
Bruker
BRKR:US
USD 597.9M
47.6M
Mar/2023
Cardinal Health
CAH:US
USD 3.99B
336M
Mar/2023
Catalent
CTLT:US
USD 442M
161M
Dec/2022
Charles River Laboratories
CRL:US
USD 201.59M
32.32M
Mar/2023
Cigna
CI:US
USD 7.94B
2.01B
Mar/2023
CVS Health
CVS:US
USD 14.62B
1.67B
Mar/2023
Danaher
DHR:US
USD 7.38B
1.38B
Mar/2023
Dentsply International
XRAY:US
USD 318M
47M
Mar/2023
Elevance Health Inc
ANTM:US
USD 10.14B
2.76B
Mar/2023
Galapagos
GLPG:NA
EUR 124.14M
383.98M
Mar/2023
Hologic
HOLX:US
USD 2.58B
140.9M
Mar/2023
Humana
HUM:US
USD 13.74B
8.67B
Mar/2023
Illumina
ILMN:US
USD 1.49B
517M
Mar/2023
Incyte Corp
INCY:US
USD 2.82B
130.37M
Mar/2023
Intrexon
XON:US
USD 9.74M
4.88M
Mar/2023
IQVIA Holdings Inc
IQV:US
USD 1.49B
278M
Mar/2023
Laboratory Of America
LH:US
USD 393.9M
36.1M
Mar/2023
Lonza Group
LONN:SW
CHF 1.34B
187M
Dec/2022
McKesson
MCK:US
USD 4.68B
1.9B
Mar/2023
Merck
MRK:GR
EUR 1.58B
270M
Mar/2023
Mettler Toledo International
MTD:US
USD 89.08M
6.88M
Mar/2023
Novartis
NOVN:VX
USD 12B
4.48B
Mar/2023
PerkinElmer
PKI:US
USD 2.27B
1.81B
Mar/2023
Quest Diagnostics
DGX:US
USD 175M
140M
Mar/2023
Thermo Fisher Scientific
TMO:US
USD 3.48B
5.04B
Mar/2023
United Therapeutics
UTHR:US
USD 1.16B
202.3M
Mar/2023
UnitedHealth
UNH:US
USD 41.91B
18.55B
Mar/2023
Veradigm Inc
MDRX:US
USD 492.6M
7.57M
Sep/2022
Walgreens Boots Alliance
WBA:US
USD 1.09B
1.26B
Dec/2022
Waters
WAT:US
USD 486.07M
5.54M
Mar/2023
West Pharmaceutical Services
WST:US
USD 886.3M
8M
Mar/2023
Financials
Stock Price
Assets
Cash and Equivalent
Cost of Sales
Current Assets
Current Liabilities
Debt
EBIT
EBITDA
Employees
EPS Earnings Per Share
Equity Capital and Reserves
Gross Profit on Sales
Interest Expense on Debt
Interest Income
Loan Capital
Market Capitalization
Net Income
Operating Expenses
Operating Profit
Ordinary Share Capital
PE Price to Earnings
Pre-Tax Profit
Sales Revenues
Selling and Administration Expenses
Stock
Trade Creditors
Trade Debtors